Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2024-11-12. Here's what investors need to know before the announcement.
Analysts estimate that Xenon Pharmaceuticals will report an earnings per share (EPS) of $-0.83.
The market awaits Xenon Pharmaceuticals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
During the last quarter, the company reported an EPS missed by $0.05, leading to a 3.19% drop in the share price on the subsequent day.
Here's a look at Xenon Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.66 | -0.76 | -0.77 |
| EPS Actual | -0.75 | -0.62 | -0.64 | -0.73 |
| Price Change % | -3.0% | -5.0% | -1.0% | -7.000000000000001% |
Market Performance of Xenon Pharmaceuticals's Stock
Shares of Xenon Pharmaceuticals were trading at $45.0 as of November 07. Over the last 52-week period, shares are up 51.26%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
